S&P 500

5.469,30

0,39%

Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Bioptix (BIOP)
Bioptix (BIOP) Notícias

BIOP

Bioptix, Inc. (BIOP)

Bioptix

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:BIOP

1 2 3 4 5 6 7 8 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
20/10/2017	19:18	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:BIOP	Bioptix
20/10/2017	19:05	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:BIOP	Bioptix
17/10/2017	10:30	PR Newswire (US)	Riot Blockchain to Acquire Majority Interest in TESS, a Blockchain Development Company	NASDAQ:BIOP	Bioptix
13/10/2017	11:36	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:BIOP	Bioptix
04/10/2017	09:26	PR Newswire (US)	Bioptix Changing Name to Riot Blockchain as Company Shifts Focus to Strategic Investor and Operator in Blockchain Technologie...	NASDAQ:BIOP	Bioptix
03/10/2017	09:30	PR Newswire (US)	Bioptix Announces Special Cash Dividend	NASDAQ:BIOP	Bioptix
25/09/2017	18:29	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3/a)	NASDAQ:BIOP	Bioptix
23/08/2017	09:30	PR Newswire (US)	Bioptix, Inc. Holds Special Shareholder Meeting	NASDAQ:BIOP	Bioptix
15/08/2017	17:56	Edgar (US Regulatory)	Amended Annual Report (10-k/a)	NASDAQ:BIOP	Bioptix
11/08/2017	18:10	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:BIOP	Bioptix
19/07/2017	18:01	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:BIOP	Bioptix
14/07/2017	18:04	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:BIOP	Bioptix
10/07/2017	18:00	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:BIOP	Bioptix
29/06/2017	18:02	Edgar (US Regulatory)	Proxy Soliciting Materials (revised) (prer14a)	NASDAQ:BIOP	Bioptix
08/05/2017	18:06	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:BIOP	Bioptix
28/04/2017	18:11	Edgar (US Regulatory)	Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)	NASDAQ:BIOP	Bioptix
20/04/2017	18:02	Edgar (US Regulatory)	Securities Registration Statement (simplified Form) (s-3)	NASDAQ:BIOP	Bioptix
10/04/2017	17:30	PR Newswire (US)	Bioptix Announces Executive Leadership Change	NASDAQ:BIOP	Bioptix
05/04/2017	15:42	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:BIOP	Bioptix
31/03/2017	17:37	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:BIOP	Bioptix
22/03/2017	17:15	Edgar (US Regulatory)	Small Company Offering and Sale of Securities Without Registration (d)	NASDAQ:BIOP	Bioptix
09/02/2017	19:32	Edgar (US Regulatory)	Amended Current Report Filing (8-k/a)	NASDAQ:BIOP	Bioptix
20/01/2017	19:30	PR Newswire (US)	Bioptix Announces Streamlining of Workforce	NASDAQ:BIOP	Bioptix
10/01/2017	09:05	Edgar (US Regulatory)	Amended Statement of Beneficial Ownership (sc 13d/a)	NASDAQ:BIOP	Bioptix
06/01/2017	19:30	PR Newswire (US)	Bioptix Reports Board of Director Changes	NASDAQ:BIOP	Bioptix
08/12/2016	19:30	PR Newswire (US)	Venaxis Reports Name Change to Bioptix, Inc and NASDAQ Ticker Symbol Change to "BIOP" from "APPY"	NASDAQ:BIOP	Bioptix
05/12/2016	12:01	Edgar (US Regulatory)	Amended Shareholder Nomination Disclosure (sc 14n/a)	NASDAQ:BIOP	Bioptix
02/12/2016	19:15	Edgar (US Regulatory)	Shareholder Nomination Disclosure (sc 14n)	NASDAQ:BIOP	Bioptix
23/09/2016	09:00	PR Newswire (US)	Venaxis Reports Option Inducement Grants for New Employees Under NASDAQ Listing Rule 5635(c)(4)	NASDAQ:BIOP	Bioptix
20/09/2016	10:00	PR Newswire (US)	Venaxis Issues Shareholder Update	NASDAQ:BIOP	Bioptix